Skip to main content

Armada Acquisition Corp. III 8-K, filed Nov 5, 2026

Armada Acquisition Corp. III (AACI)

8-K 2026-11-05 For: 2026-10-31
View Original
Added on November 05, 2026

About this 8-K

Armada Acquisition Corp. III filed this 8-K on November 5, 2026, reporting on events of October 31, 2026.

Armada Acquisition Corp. III entered a Business Combination Agreement with Brains Bioceutical Corp. on October 31, 2026, valuing Brains at a $750.0 million enterprise value. The deal includes 14,705,882 earnout shares tied to $12.50 and $15.00 price targets. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits